Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Claritas Capital is a Nashville-based private investment firm and alternative asset manager that invests across venture capital and real estate, with a meaningful focus on healthcare and health tech. The firm reports more than $1 billion in deployed capital, a history dating to 2002, and a portfolio spanning over 100 venture-backed companies and more than 50 real estate deals. Its healthcare activity is conducted in part through Claritas Health Ventures, which backs companies focused on clinical excellence, patient experience, access, equity, and cost reduction. Rather than operating as a drug developer, Claritas Capital functions as an investor and strategic partner to entrepreneurs in healthcare, technology, and related sectors. For a biotech or healthcare analyst, the firm is best understood as a healthcare-focused investment platform rather than a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Claritas Capital.